Philippe Barillon’s Post

View profile for Philippe Barillon, graphic

Global Biopharma Leader | Boosting Growth with AI | Quiet extrovert

As a strategic advisor, I'm frequently asked about patient-first go-to-market strategies. The answer is simple: it all starts with defining WHO your patient is. Traditional approaches often confuse the label (who can get this drug) with strategic patient positioning (who should get this drug). By making a strategic choice within the label, you can create a patient-first strategy that prioritizes the needs of your patients. Once this #1 choice is made, the rest is just mapping and activating. Want to know more ? Please reach out! #PatientFirst #GoToMarketStrategy #StrategicPositioning

Anas B.

Solving the impossible | Big Data & AI for better treatments and Healthier People

7mo

Absolutely spot on! Distinguishing between the label and strategic patient positioning is key. It's not just about who can receive the drug but who should for optimal outcomes*. A Patient-first approach prioritizes patient needs by aligning business objectives with patient centric values and an ethical delivery 🙌

To view or add a comment, sign in

Explore topics